Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 308-314, March 2003

Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: Protection by nitric oxide donor☆

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, and the Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan

Received 6 April 2002; accepted 28 September 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address reprint requests to Masanori Iwase, MD, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan.

PII: S0026-0495(02)05265-4

doi:10.1053/meta.2003.50049

Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 308-314, March 2003

Article Tools